Chinese scientists discover gene associated with prostate cancer
The research reveals that PCSEAT is overexpressed in prostate cancer patients, indicating that PCSEAT may be a potential therapeutic target
Beijing: Chinese scientists have identified a new gene strongly associated with prostate cancer, offering new methods for diagnosis and treatment of the disease. The newly identified biomarker, PCSEAT, was discovered by scientists from Suzhou Institute of Biomedical Engineering and Technology, state-run Xinhua news agency reported.
The research reveals that PCSEAT is overexpressed in prostate cancer patients, indicating that PCSEAT may be a potential therapeutic target. The research was published in the journal Biochemical and Biophysical Research Communications in May.
Based on the research, they have developed an early diagnosis for prostate cancer and applied for a patent. The application can significantly improve the accuracy of prostate cancer diagnosis and reduce the cost of diagnosis and treatment. China has seen increasing cases of prostate cancer in recent years.
- Diabetes treatment gets boost from ‘surgery in a pill’: Study
- Scientists develop technology to recycle vaporised water from power plants for drinking needs
- Star system with three Earth-sized planets discovered
- Boosting self-destruction of cells can help us live longer: Study
- Scientists hunt down genes behind the big human brain
Editor's Picks »
- RBI wants banks to discipline Indian corporates on working capital
- For stressed power assets resolution, patience is the virtue for banks, govt
- Exide’s valuation zooms as it claws back market share lost to Amara Raja
- Trapped in mid-cap stocks? What investors should do
- TCS share buyback shows absurdities of India’s repurchase rules